{"chebi_id":"177746","chebi_name":"Golvatinib","chebi_synonyms":["1-N'-[2-luoro-4-[2-[[4-(4-methylpiperazin-1-yl)piperidine-1-carbonyl]amino]pyridin-4-yl]oxyphenyl]-1-N-(4-luorophenyl)cyclopropane-1,1-dicarboxamide"],"diffprof_id_observed":["MTBLS2871_0002_00000009"],"diffprof_id_var_observed":["MTBLS2871_0002_00000009"],"inchikey":"UQRCJCNVNUFYDX-UHFFFAOYSA-N","inn_name":"","iupac_name":"1-N'-[2-luoro-4-[2-[[4-(4-methylpiperazin-1-yl)piperidine-1-carbonyl]amino]pyridin-4-yl]oxyphenyl]-1-N-(4-luorophenyl)cyclopropane-1,1-dicarboxamide","num_study_observed":1,"reactome_ids":["R-HSA-162582","R-HSA-6806834","R-HSA-6806942","R-HSA-6807004","R-HSA-9006934","R-HSA-9734091"],"reactome_names":["Signal Transduction","Signaling by MET","MET Receptor Activation","Negative regulation of MET activity","Signaling by Receptor Tyrosine Kinases","Drug-mediated inhibition of MET activation"],"study_id_observed":["MTBLS2871"],"study_id_var_observed":["MTBLS2871"],"synonym_name":""}